Advertisement

Updated May 7th, 2021 at 09:54 IST

Kamal Nath alleges slow pace of COVID-19 vaccination in MP; questions govt on stock

On Friday, senior Congress leader and MLA Kamal Nath slammed the Madhya Pradesh government for the alleged slow pace of COVID-19 vaccination in the state.

Reported by: Akhil Oka
Kamal Nath, Madhya Pradesh
Image: PTI | Image:self
Advertisement

On Thursday, senior Congress leader Kamal Nath slammed the Madhya Pradesh government for the alleged slow pace of COVID-19 vaccination in the state. A total of 71,46,091 persons have been inoculated in MP till now, 13,44,189 of them have received the second dose of the vaccine too. Claiming that people are under stress owing to the lack of enough vaccination centres, he lamented that no one knows when the vaccines ordered by the state government would be supplied. 

Taking to Twitter, Kamal Nath wrote, "By the current pace, it will take years for residents of the state to get vaccinated. But our publicity-hungry CM is spending crores of rupees amid the pandemic in spreading fake news. While he is encouraging people to get vaccinated and propagating the benefits of inoculation through advertisements, where are the vaccines? This money could have been used for ramping up the health infrastructure at this time of crisis."

It is pertinent to note that the MP government has placed purchase orders with the Serum Institute of India and Bharat Biotech for a requirement of 5.29 crore doses. All adults in the state are now eligible to be inoculated free of cost. At present, there are 88,614 active novel coronavirus cases in TN while 5,42,632 patients have recovered and 6160 deaths have been reported

India opens up vaccination for all adults

Apart from COVISHIELD and COVAXIN, the DCGI accepted the recommendations of the Subject Expert Committee of the Central Drugs Standard Control Organisation, paving way for the approval of Sputnik V on April 12. Moreover, the Union government declared that those vaccines that have been granted emergency approval for restricted use by USFDA, EMA, UK MHRA, PMDA Japan, or which are listed in WHO (Emergency Use Listing) will be granted emergency use approval in India. In a huge announcement on April 19, the Centre relaxed the age bar for vaccination from May 1 onwards and mentioned that vaccine manufacturers can supply 50 per cent of its doses to state governments and in the open market.

The private hospitals shall have to procure their supplies of the COVID-19 vaccines exclusively from this quota. At the same time, vaccination shall continue at Government of India vaccination centres for healthcare and frontline workers and those above 45 years. Additionally, the Centre stated that it will allocate vaccine doses to the states from the remaining 50% quota based on factors such as the number of active cases, speed of administration and vaccine wastage.

Advertisement

Published May 7th, 2021 at 09:54 IST

Your Voice. Now Direct.

Send us your views, we’ll publish them. This section is moderated.

Advertisement
Advertisement

Trending Quicks

Kerala Nirmal Lottery Sambad Friday Result
a few seconds ago
TMC Delgation at ECI Office
3 minutes ago
Congress Press Conference
9 minutes ago
Raw Mango
10 minutes ago
Gen Z worker goes to the salon while “working from home”
12 minutes ago
Lionel Messi
13 minutes ago
Jailed Gangster Mukhtar Ansari Passes Away
15 minutes ago
Lok Sabha Elections 2024 LIVE
18 minutes ago
Tie-dye printed shirts
23 minutes ago
Sri Lanka on High Alert on Good Friday
24 minutes ago
Gautam Gambhir gets into a fight with Virat Kohli
25 minutes ago
Advertisement
Advertisement
Advertisement
Whatsapp logo